OpenURL Connection Search

Select item for more details and to access through your institution.

Corrigendum: Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4+ T cells.
Published in:
2009
By:
- Hutnick, Natalie A;
- Carnathan, Diane G;
- Dubey, Sheri A;
- Makedonas, George;
- Cox, Kara S;
- Kierstead, Lisa;
- Ratcliffe, Sarah J;
- Robertson, Michael N;
- Casimiro, Danilo R;
- Ertl, Hildegund C J;
- Betts, Michael R
Publication type:
Correction Notice
Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4+ T cells.
Published in:
Nature Medicine, 2009, v. 15, n. 8, p. 876, doi. 10.1038/nm.1989
By:
- Hutnick, Natalie A.;
- Carnathan, Diane G.;
- Dubey, Sheri A.;
- Cox, Kara S.;
- Kierstead, Lisa;
- Ratcliffe, Sarah J.;
- Robertson, Michael N.;
- Casimiro, Danilo R.;
- Ertl, Hildegund C. J.;
- Betts, Michael R.
Publication type:
Article
P4-380: The challenges to the development of a safety biomarker assay to detect amyloid-β–specific T cell activation
Published in:
2008
By:
- Lash, Holly A.;
- Talaty, Jennifer E.;
- Rosen, Laura B.;
- Reynolds, James M.;
- Sikkema, Daniel J.;
- Kierstead, Lisa S.
Publication type:
Abstract
Vaccination with Ad5 Vectors Expands Ad5-Specific CD8+ T Cells without Altering Memory Phenotype or Functionality.
Published in:
PLoS ONE, 2010, v. 5, n. 12, p. 1, doi. 10.1371/journal.pone.0014385
By:
- Hutnick, Natalie A.;
- Carnathan, Diane G.;
- Dubey, Sheri A.;
- Cox, Kara S.;
- Kierstead, Lisa;
- Makadonas, George;
- Ratcliffe, Sarah J.;
- Lasaro, Marcio O.;
- Robertson, Michael N.;
- Casimiro, Danilo R.;
- Ertl, Hildegund C. J.;
- Betts, Michael R.
Publication type:
Article
Comparative Cell-Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV-1 Clade B gag Vaccine Prime-Boost Regimens.
Published in:
Journal of Infectious Diseases, 2010, v. 201, n. 1, p. 132, doi. 10.1086/648591
By:
- Asmuth, David M.;
- Brown, Elizabeth L.;
- DiNubile, Mark J.;
- Xiao Sun;
- del Rio, Carlos;
- Harro, Clayton;
- Keefer, Michael C.;
- Kublin, James G.;
- Dubey, Sheri A.;
- Kierstead, Lisa S.;
- Casimiro, Danilo R.;
- Shiver, John W.;
- Robertson, Michael N.;
- Quirk, Erin K.;
- Mehrotra, Devan V.
Publication type:
Article
Robust validation and performance comparison of immunogenicity assays assessing IgG and neutralizing antibodies to SARS-CoV-2.
Published in:
PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0262922
By:
- Bonhomme, Marie E.;
- Bonhomme, Cyrille J.;
- Strelow, Lisa;
- Chaudhari, Atul;
- Howlett, Adrienne;
- Breidenbach, Carl;
- Hester, Jack;
- Hammond, Christopher;
- Fuzy, Michéal;
- Harvey, Laura;
- Swanner, Vanessa;
- Ellis, Jeymie;
- Greway, Rebecca R.;
- Pisciella, Victoria A.;
- Green, Tina;
- Kierstead, Lisa
Publication type:
Article
Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy Adults.
Published in:
Clinical Infectious Diseases, 2008, v. 46, n. 11, p. 1769, doi. 10.1086/587993
By:
- Priddy, Frances H.;
- Brown, Deborah;
- Kublin, James;
- Monahan, Kathleen;
- Wright, David P.;
- Lalezari, Jacob;
- Santiago, Steven;
- Marmor, Michael;
- Lally, Michelle;
- Novak, Richard M.;
- Brown, Stephen J.;
- Kulkarni, Priya;
- Dubey, Sheri A.;
- Kierstead, Lisa S.;
- Casimiro, Danilo R.;
- Mogg, Robin;
- DiNubile, Mark J.;
- Shiver, John W.;
- Leavitt, Randi Y.;
- Robertson, Michael N.
Publication type:
Article

Found: 7

Corrigendum: Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4<sup>+</sup> T cells.

Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4<sup>+</sup> T cells.

P4-380: The challenges to the development of a safety biomarker assay to detect amyloid-β–specific T cell activation

Vaccination with Ad5 Vectors Expands Ad5-Specific CD8<sup>+</sup> T Cells without Altering Memory Phenotype or Functionality.

Comparative Cell-Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV-1 Clade B gag Vaccine Prime-Boost Regimens.

Robust validation and performance comparison of immunogenicity assays assessing IgG and neutralizing antibodies to SARS-CoV-2.

Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy Adults.